NTRK1 and breast carcinoma: Subsequent investigations demonstrated that knockdown of ABL kinase resulted in decreased TAZ mRNA expression and reduced binding between TAZ and its downstream target AXL, a receptor tyrosine kinase that promotes breast cancer bone metastasis, and breast cancer bone metastasis was inhibited (58).